You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and explain in detail?
Grundy et al. (2018) provide a comprehensive set of clinical statements and guidelines for reducing the risk of atherosclerotic cardiovascular disease (ASCVD) through cholesterol management. The guidelines recommend high-intensity statin therapy for patients with LDL-C levels ≥190 mg/dL and moderate-intensity statin therapy for those with LDL-C levels ≥70 mg/dL and diabetes mellitus. The document also covers topics such as biomarkers, coronary artery calcium score, pharmacological treatments, cardiovascular disease, cholesterol, LDL-cholesterol, diabetes mellitus, drug therapy, and more.